169 related articles for article (PubMed ID: 20516539)
1. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
Motazedian S; Babakhani L; Fereshtehnejad SM; Mojthahedi K
Indian J Med Res; 2010 May; 131():670-4. PubMed ID: 20516539
[TBL] [Abstract][Full Text] [Related]
2. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
[TBL] [Abstract][Full Text] [Related]
3. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
Bahceci M; Sismanoglu A; Ulug U
Gynecol Endocrinol; 2010 Jul; 26(7):505-8. PubMed ID: 20459348
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
Eftekhari N; Mohammadalizadeh S
Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
7. [Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
Pascal-Vigneron V; Weryha G; Bosc M; Leclere J
Presse Med; 1995 Apr; 24(16):753-7. PubMed ID: 7784413
[TBL] [Abstract][Full Text] [Related]
8. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
[TBL] [Abstract][Full Text] [Related]
10. Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
Aydin Y; Atis A; Kaleli S; Uludağ S; Goker N
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):203-6. PubMed ID: 20206430
[TBL] [Abstract][Full Text] [Related]
11. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Krysiak R; Okopien B
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
13. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Prathibha D; Govardhani M; Krishna PT
J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia: etiology, diagnosis, and management.
Mah PM; Webster J
Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
[TBL] [Abstract][Full Text] [Related]
15. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
dos Santos Nunes V; El Dib R; Boguszewski CL; Nogueira CR
Pituitary; 2011 Sep; 14(3):259-65. PubMed ID: 21221817
[TBL] [Abstract][Full Text] [Related]
16. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
Colao A; Di Sarno A; Guerra E; De Leo M; Mentone A; Lombardi G
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):200-10. PubMed ID: 16932285
[TBL] [Abstract][Full Text] [Related]
17. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
18. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
19. Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
Jones TH; Fraser RB
Br J Obstet Gynaecol; 1994 Apr; 101(4):349-50. PubMed ID: 7911037
[No Abstract] [Full Text] [Related]
20. Occult hyperprolactinemia in infertile women.
Asukai K; Uemura T; Minaguchi H
Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
